What if we could eliminate viruses as current and future health threats?
APECx (Antigens Predicted for Broad Viral Efficacy through Computational Experimentation) aims to transform vaccine antigen discovery, first by developing toolkits that successfully design broadly effective antigens, targeting entire viral families, and then demonstrating the toolkits’ accuracy by evaluating candidate vaccine antigens in clinical trials. If successful, the APECx toolkit and subsequent product development will demonstrate the possibility of broadly effective vaccines against multiple virus threats and eliminate entire types of viruses that are responsible for causing cancer, autoimmune disease, chronic illness, emerging infections, and potential pandemics. Program Manager: Andy Kilianski, Ph.D. Learn more at https://arpa-h.gov/engage/programs/ap...

ARPA-H Cancer Community Conversation (7/15/24)

A New Hope for Restoring Sight

HEARING Program Proposers' Day Presentation (June 8, 2026)

TIGAR ET Webinar (May 20, 2026)

The ARPA-H Nationwide Health Innovation Network, ARPANET-H

STOMP Proposers' Day Presentation (4/22/26)

ARPA-H Reimagines the Future of Indoor Air

BRAINS Exploratory Topic Webinar (June 9, 2026)

Small Business Program Proposers' Day Presentation (June 11, 2026)

ARPA-H launches groundbreaking program to restore natural hearing through first brain-driven system

IGoR Proposers' Day Presentation (June 9, 2026)

Dallas: ARPA-H on the Ground

Chris Molaro, NeuroFlow ~ EVIDENT Mental Health Awareness Month Testimonial

ARPA-H launches new program to deliver rigorous, gold-standard research faster

Jesse MacLachlan ~ EVIDENT Mental Health Awareness Month Testimonial

TIGAR: Advancing biopreservation capabilities for tissues and organs

Adam Marr ~ EVIDENT Mental Health Awareness Month Testimonial

General Martin Steele ~ EVIDENT Mental Health Awareness Month Testimonial

